- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 277/60 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 277/60
Total number of patents in this class: 195
10-year publication summary
18
|
13
|
21
|
14
|
11
|
9
|
10
|
7
|
9
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
EyePoint Pharmaceuticals, Inc. | 98 |
11 |
Piramal Enterprises Limited | 157 |
9 |
LG Chem, Ltd. | 17639 |
6 |
Boehringer Ingelheim International GmbH | 4754 |
6 |
Ligand Pharmaceuticals Incorporated | 120 |
6 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 806 |
6 |
Bristol-myers Squibb Company | 4863 |
5 |
Takeda Pharmaceutical Company Limited | 2943 |
5 |
Duke University | 3011 |
4 |
Chaperone Therapeutics, Inc | 6 |
4 |
PGI Drug Discovery LLC | 27 |
4 |
Rohm and Haas Electronic Materials Korea Ltd. | 330 |
4 |
Sunovion Pharmaceuticals Inc. | 290 |
4 |
Idorsia Pharmaceuticals Ltd. | 363 |
4 |
The Regents of the University of California | 19517 |
3 |
Merck Sharp & Dohme Corp. | 2219 |
3 |
CHDI Foundation, Inc. | 108 |
3 |
Connexios Life Sciences Pvt. Ltd. | 13 |
3 |
Masarykova Univerzita | 71 |
3 |
Motac Neuroscience Limited | 5 |
3 |
Other owners | 99 |